CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Magnet Resonance Imaging (MRI) +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04204876
NCT04204876N/ACompleted
CompareCT.gov

Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease Course

University Hospital, Basel, Switzerland·observational·Posted Dec 19, 2019·Updated Jan 18, 2024

In Brief

An observational study evaluating Magnet Resonance Imaging (MRI) and PET/CT analysis for Giant Cell Arteritis and Large Vessel Giant Cell Arteriitis. Completed, enrolled 40 participants across 1 site.

Detailed Summary

Longitudinal imaging in patients with large vessel vasculitis to predict further disease course

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGiant Cell Arteritis, Large Vessel Giant Cell Arteriitis
CountriesSwitzerland
CollaboratorsSwiss Foundation for the Study of Muscular Diseases

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedDec 19, 2019
Enrollment StartMay 28, 2020
Primary CompletionAug 5, 2023
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 6.5 years ago

Interventions

Magnet Resonance Imaging (MRI)other

MRI with and without Gadolinium contrast agent for the following vessels: thoracic aorta (ascending, arch, descending arch, left and right common carotic, subclavian, and vertebral artery)

PET/CT analysisother

Standard value uptake measurement (SUV) based on quantitative score normalized to liver (SUV vessel max/liver mean) at the following vessel regions: Carotid artery: common, internal, external; Subclavian artery; Axillary artery; Vertebral artery; Thoracic Aorta; Abdominal Aorta; Common femoral artery; Deep femoral artery; Popliteal artery